TECHFIT Digital Surgery Announces Know-How License Agreement and Stock Purchase Agreement with Mayo Clinic

Daytona Beach, FL Jan 14, 2022. TECHFIT Digital Surgery announced that Mayo Clinic became a shareholder as part of a know-how collaboration with a stock purchase agreement. The aim of this collaboration is to develop a patient-specific 3D printed implantable solutions for chest wall reconstruction manufactured from the PEEK biomaterial. TECHFIT implants have been used in the world’s first PEEK patient-specific chest-wall implants with a pending patent. TECHFIT and Mayo Clinic seek to obtain a deeper understanding of new design customized protocols that allow each patient to benefit from PEEK, a material with very similar mechanical properties to the bone, an extraordinary fatigue life, and widely understood biocompatibility. “Our goal is to make custom medical devices the new standard of care for musculoskeletal pathologies. The right software platform is required as are the proper manufacturing protocols for patients and surgeons to obtain exponential benefits.” said Mauricio Velez MD, Chairman and Co-Founder of TECHFIT Digital Surgery. TECHFIT is a Florida-based startup that develops integrated digital platforms where surgeons and engineering teams collaborate on the design of implants and instruments specifically designed for every patient. These designs are custom manufactured to the specific patient’s needs using TECHFIT’s manufacturing network and 3D printers installed at the point of care. To date, more than 2,500 patients worldwide have benefitted from TECHFIT Digital Surgery’s solutions. The startup recently included the US market with an FDA clearance for custom-made maxillofacial plates.